Ovid Application Error
Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19. Ananworanich, Jintanat; Mogg, Robin; Dunne, Michael W; Bassyouni, Mohamed; David, Consuela Vera; Gonzalez, Erika; Rogalski-Salter, Taryn; Shih, Heather; Silverman, Jared; Medema, Jeroen; Heaton, Penny [Article] Clinical Infectious Diseases.
(Format: HTML, PDF)